Kongressthemen Following two successful virtual experiences, the 3rd JAK Inhibitors Drug Development Summit is making its way to Boston, MA warmly welcoming the JAK inhibitor community back to in-person meetings.
We are uniting this diverse community of world-leading experts from a range of therapeutic backgrounds all tied together by one thing, treating dermatologic, autoimmune, oncologic and many more inflammatory indications through JAK inhibition.
Speakers: Brett King MD, Associate Professor, Dermatology, Yale University School of Medicine, Wilma Bergfeld, MD Director of Dermatopathology Fellowship, The Cleveland Clinic, and more.
